Sohail Ikram, M.D., FACC

Sohail Ikram, M.D. FACC

Sohail Ikram, M.D. FACC

UofL Physicians Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-7959- Academic Office
502-588-4600 - Patient Appointments


Clinical Expertise
Invasive and Interventional Cardiology; Endovascular Interventions; Transthoracic, Transesophageal and Stress Echocardiography; Nuclear Cardiology; General Cardiology


Board Certifications

  • American Board of Internal Medicine -
    Cardiovascular Disease / Interventional Cardiology

Education and Training

  • Medical School: Rawalpindi Medical College, Punjab University Pakistan
  • Residency: University of Louisville Hospital
  • Fellowship: Washington Hospital Center (Peripheral Vascular Intervention); University of Louisville (Interventional Cardiology / Cardiovascular Diseases)

Get To Know Dr. Ikram


Featured Publications

  • Shah SR, Ali A, Ikram S. Sotagliflozin and decompensated heart failure: results of the SOLOIST-WHF trial. Expert Rev Clin Pharmacol. 2021 May;14(5):523-525. doi: 10.1080/17512433.2021.1908123. Epub 2021 Apr 9. PMID: 33764842.
  • Bolli R, Mitrani RD, Hare JM, Pepine CJ, Perin EC, Willerson JT, Traverse JH, Henry TD, Yang PC, Murphy MP, March KL, Schulman IH, Ikram S, Lee DP, O'Brien C, Lima JA, Ostovaneh MR, Ambale-Venkatesh B, Lewis G, Khan A, Bacallao K, Valasaki K, Longsomboon B, Gee AP, Richman S, Taylor DA, Lai D, Sayre SL, Bettencourt J, Vojvodic RW, Cohen ML, Simpson L, Aguilar D, Loghin C, Moyé L, Ebert RF, Davis BR, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN). A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail. 2021 Apr;23(4):661-674. doi: 10.1002/ejhf.2178. Epub 2021 Apr 13. PMID: 33811444.
  • Shah SR, Ali A, Ikram S. Omecamtiv Mecarbil use in systolic heart failure-Results of the GALACTIC-HF trial. Expert Rev Clin Pharmacol. 2021 Apr;14(4):407-409. doi: 10.1080/17512433.2021.1900727. Epub 2021 Mar 25. PMID: 33689561.
  • Bolli R, Perin EC, Willerson JT, Yang PC, Traverse JH, Henry TD, Pepine CJ, Mitrani RD, Hare JM, Murphy MP, March KL, Ikram S, Lee DP, O'Brien C, Durand JB, Miller K, Lima JA, Ostovaneh MR, Ambale-Venkatesh B, Gee AP, Richman S, Taylor DA, Sayre SL, Bettencourt J, Vojvodic RW, Cohen ML, Simpson LM, Lai D, Aguilar D, Loghin C, Moyé L, Ebert RF, Davis BR, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN). Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial. JACC CardioOncol. 2020 Nov;2(4):581-595. doi: 10.1016/j.jaccao.2020.09.001. Epub 2020 Dec 22. PMID: 33403362; PMCID: PMC7781291.
  • Khan MS, Moustafa A, Azhar AZ, Khan AR, Ikram S. Aspirin-free strategy versus standard term dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2020 May 29:2047487320925623. doi: 10.1177/2047487320925623. Epub ahead of print. PMID: 33611543.
  • Khan MS, Moustafa A, Azhar AZ, Khan AR, Ikram S. Aspirin-free strategy versus standard term dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2020 May 29:2047487320925623. doi: 10.1177/2047487320925623. Epub ahead of print. PMID: 32469617.
  • Raza M, Ikram S, Williams N, Otero D, Barry N, Kelsey N, Kahlon T, Singh V. Cardiac Lymphoma Presenting with Recurrent STEMI. Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):158-161. doi: 10.14797/mdcj-16-2-158. PMID: 32670477; PMCID: PMC7350821.
  • Khan MS, Khan AR, Khan AI, Seo M, Yasmin F, Usman MS, Moustafa A, Schmid CH, Kalra A, Ikram S. Comparison of revascularization strategies in patients with acute coronary syndrome and multivessel coronary disease: A systematic review and network meta-analysis. Catheter Cardiovasc Interv. 2020 Oct 1;96(4):E447-E454. doi: 10.1002/ccd.28855. Epub 2020 Mar 28. PMID: 32222063.
  • Singam NSV, Burkhart T, Ikram S. Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis. Methodist Debakey Cardiovasc J. 2019 Jul-Sep;15(3):223-225. doi: 10.14797/mdcj-15-3-223. PMID: 31687103; PMCID: PMC6822649.
  • Ikram S, Pachika A, Schuster H, Ghotra A, Dotson L, Akbar S, Khan AR. Single-Center Retrospective Study of Risk Factors and Predictive Value of Framingham Risk Score of Patients with ST Elevation Myocardial Infarction. South Med J. 2018 Apr;111(4):226-229. doi: 10.14423/SMJ.0000000000000785. PMID: 29719035.